SAFE notes have progressively replaced convertible notes as the reference instrument for early funding rounds. Quick to put in place, they allow startups to raise capital without negotiating an immediate valuation: a decisive advantage at the seed stage.
But beneath that apparent simplicity lie conversion mechanics, dilution effects, and valuation challenges that neither founders nor investors can afford to ignore.
What Is a SAFE Note?
Origin
SAFE stands for Simple Agreement for Future Equity. The instrument was created by Y Combinator in 2013 to simplify early funding rounds for startups.
Unlike a convertible note, a SAFE note is neither debt nor immediate equity. It is a contractual right entitling the investor to receive shares upon a future event, typically a qualified financing round, an acquisition, or an IPO. It carries no interest and has no fixed maturity date.
A convertible note, by contrast, is debt carrying an interest rate and a maturity date. If no qualified raise occurs before that date, the debt becomes repayable, which can place significant pressure on a startup's cash position. A SAFE does not sit on the balance sheet as a financial liability, but its lack of repayment structure makes valuation more complex for fund managers.
In short, a SAFE note differs from a convertible note on four key points:
- It carries no interest
- It has no maturity date
- It is not repayable in the absence of a qualified raise (except upon dissolution)
- It generates greater cap table complexity when multiple SAFEs coexist
How Does a SAFE Note Work?
The mechanism is straightforward: the investor provides capital today in exchange for a right to convert into shares at a later date, under pre-agreed conditions.
Conversion occurs automatically upon a qualified equity financing, meaning a funding round exceeding a defined threshold. At that point, the capital raised via SAFE converts into shares at the price per share of that round, adjusted where applicable by a discount rate or a valuation cap.
Key Mechanisms of a SAFE Note
The Valuation Cap
The valuation cap is the maximum valuation at which the SAFE converts. It protects the early-stage investor by guaranteeing a favourable conversion price, even if the startup raises its next round at a significantly higher valuation.
Example: an investor subscribes a SAFE with a valuation cap of £5m. The startup subsequently raises a Series A at a £15m valuation. The investor converts on the basis of the £5m cap, obtaining a larger ownership stake than Series A investors.
The Discount Rate
The discount rate allows the SAFE investor to convert at a reduced price relative to the next round's share price. A 20% discount means the investor pays £0.80 for every £1 of shares issued in the subsequent raise.
When both mechanisms are present, conversion applies whichever condition is most favourable to the investor.
The MFN Clause (Most Favoured Nation)
In SAFEs without a cap or discount, an MFN clause may be included. It guarantees the investor automatically benefits from any more favourable terms granted to future investors. It is a common safeguard in very early cheques.
Conversion and Liquidity Events
Beyond a qualified financing round, SAFE notes typically include exit clauses in the event of acquisition or dissolution. In this scenario, the investor recovers the invested amount as a priority, or receives shares if the exit valuation allows. Clearly defining liquidation rights at the drafting stage, whether in a partial or full exit, avoids significant disputes later on.
Why Are SAFE Notes Popular in Venture Capital?
From the Founders' Perspective
SAFE notes are valued for their speed of execution. A standard agreement can be signed within days, without complex valuation negotiations. This is a decisive advantage when a startup needs capital quickly to seize an opportunity or extend its runway.
They also allow founders to defer the valuation discussion to a point where the startup has more evidence to support a stronger number, reducing the risk of early undervaluation.
From the Investors' Perspective
For business angels and early-stage funds, SAFEs offer a fast entry point with downside protection via the valuation cap. Terms are standardised, keeping legal costs low.
That said, they confer fewer formal rights than traditional preferred shares: no board seat, no voting rights prior to conversion, and limited visibility on cap table evolution if the startup issues successive SAFEs over time.
Limitations to Keep in Mind
Despite their apparent simplicity, SAFE notes can complicate the capital structure over time. The accumulation of SAFEs with varying caps, combined with options and warrants, makes the cap table increasingly difficult to read, both for incoming investors and auditors.
Furthermore, without formal rights attached, SAFE investors have limited contractual levers to monitor the financial health of the startup between issuance and conversion. This is partly why SAFE notes and venture debt play complementary roles: venture debt, deployed at a later stage, comes with covenants and structured monitoring that a SAFE does not provide.
Impact on the Cap Table and Valuation
Deferred Dilution: An Underestimated Risk
One of the main pitfalls of SAFE notes for founders is the deferred dilution effect. At issuance, no new shares are created. Dilution only materialises at conversion (sometimes several years later).
If several SAFE notes have been issued with different caps, simultaneous conversion at Series A can result in significantly greater dilution than originally anticipated. This phenomenon, known as SAFE overhang, must be carefully modelled ahead of any institutional round.
Valuing SAFE Notes in a Portfolio
For asset managers and venture capital funds, valuing SAFE notes held in portfolio presents specific challenges.
Prior to conversion, the fair value of a SAFE must be estimated by factoring in the probability of conversion, the expected timeline, and prevailing market conditions. IFRS 9 standards and IPEV guidelines provide the relevant framework, though they leave considerable room for interpretation.
Key inputs for a SAFE valuation model include: the valuation cap, the discount rate, the implied valuation of the startup at the assessment date, and anticipated exit scenarios.
Waterfall Modelling in the Presence of SAFEs
In an acquisition or liquidation scenario, SAFE notes are typically ranked above ordinary shares but below debt. Their exact position in the waterfall depends on the contractual clauses, notably the presence or absence of a liquidation preference.
This structural ambiguity makes waterfall modelling more complex when multiple SAFE notes, convertible notes, and preferred shares coexist within the same capital structure. A careful reading of LPAs and term sheets is essential.
How ScaleX Invest Helps You Navigate These Challenges
ScaleX Invest supports fund managers with dedicated tools:
- Modelling of all capital instruments (ordinary shares, preferred shares, SAFEs, convertible notes, warrants)
- Simulation of the impact of each conversion scenario on the cap table
- Fair value calculation compliant with IFRS 9 standards and IPEV guidelines
Through consolidated dashboards and integration APIs, SAFE exposure tracking, conversion trigger detection, and LP report generation are fully automated.
Conclusion
SAFE notes are a powerful early-stage financing tool, valued for their simplicity and speed of execution. They offer genuine flexibility to founders and a favourable entry point for early-stage investors.
But beneath that apparent simplicity lie modelling, valuation, and cap table management challenges that cannot be overlooked. For asset managers, tracking and valuing these instruments with precision is a prerequisite for sound portfolio management.
FAQ
SAFE note or convertible note: what is the difference and which one to choose?
A convertible note is interest-bearing debt with a maturity date, repayable if no qualifying raise occurs. A SAFE note is not debt: it carries no interest, has no maturity date, and is not repayable in the absence of a qualified round. In the UK, both instruments are used at the seed stage, with SAFEs increasingly favoured for their simplicity and lower legal costs.
SAFE note: what rights does the investor hold before conversion?
Before conversion, a SAFE investor holds no shares and has no voting rights. There is no board seat or formal information rights either, unless specifically negotiated. This is one of the structural limitations of the instrument compared to a standard preferred share.
When does a SAFE note convert into shares?
Conversion occurs upon a qualified equity financing, an acquisition, or an IPO. In a dissolution scenario, the investor recovers their initial investment as a priority.
SAFE note and dilution: how does SAFE overhang work?
SAFE overhang refers to the accumulated dilution effect when multiple SAFEs with different caps convert simultaneously at a priced round. Founders often underestimate the total impact until Series A, where the dilution can be significantly larger than anticipated.
How does a SAFE note affect a fund's valuation?Before conversion, a SAFE is accounted for as a financial instrument whose fair value evolves with the startup's progress. It can influence the fund's NAV, particularly following a significant raise or a change in the borrower's risk profile.
